Digital Dialectical Behavioral Therapy (d-DBT) Skills for Acute

Status Completed

Clinical Trial Summary

Suicidality (ideation about taking one's life, suicide plans, and attempts) is a major public health concern in Ontario and worldwide. Psychiatric inpatients with suicidality represent a group that is high-risk for subsequent suicide. Current standard-care for suicidal psychiatric inpatients focuses on containment of risk and indirect treatment of suicidality by treating any underlying mental disorder. Though there is evidence that addressing suicidality directly is more effective than an indirect approach, there are limited evidence based treatments that target suicidality. Furthermore, there are few high-quality studies that have included inpatients. Psychotherapeutic interventions are under-utilized for inpatients and COVID-19 has further widened this gap given attempts by hospitals to reduce face-to-face contact with patients. Digital psychotherapy interventions have the ability to bridge this gap given their lower cost, ease of dissemination, acceptability by patients, and effectiveness. To our knowledge, there are no studies that have assessed the feasibility, acceptability and effectiveness of digital interventions for suicidal inpatients. Our study is a feasibility trial of a previously studied digital Dialectical Behavioural Therapy (d-DBT) skills intervention in suicidal psychiatric inpatients. The study is a two arm randomized parallel group-controlled trial, 6-10 day, flexible timeline, randomized feasibility trial of a d-DBT skills intervention added to standard care for patients admitted to psychiatric inpatient units with suicidality. There will be 20 patients who will receive the intervention in addition to standard care and 20 patients who will receive standard care alone. There will also be a 4 week follow-up after discharge from hospital. Participants will be admitted for psychiatric care at the Complex and Critical Care Units, Centre for Addiction and Mental Health (CAMH), Toronto.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Suicidal Ideation

Clinical Trial Details

NCT number	NCT05045677
Study type	Interventional
Source	Centre for Addiction and Mental Health
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2022
Completion date	November 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05334381` - Navigating Mental Health Treatment for Black Youth	N/A
Recruiting	`NCT04653337` - Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression	Phase 2
Terminated	`NCT04254809` - Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts	N/A
Recruiting	`NCT05848089` - Real-time Intervention for Suicide Risk Reduction	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed	`NCT05280756` - Home-based tDCS for Prevention of Suicidal Ideation	N/A
Not yet recruiting	`NCT06454136` - Pilot Trial of Mobile Technology for Adolescent Suicidality	N/A
Completed	`NCT01944293` - Ketamine for Suicidality in Bipolar Depression	Phase 1/Phase 2
Completed	`NCT02021344` - Mental Health First Aid for College Students	N/A
Not yet recruiting	`NCT04686162` - Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy	N/A
Recruiting	`NCT05377177` - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI	N/A
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT05925322` - Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality	N/A
Not yet recruiting	`NCT05427734` - Treating Drivers of Suicide Using Jaspr Health	N/A
Recruiting	`NCT04112368` - Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach	Phase 4
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Recruiting	`NCT05537376` - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness	N/A
Not yet recruiting	`NCT06311591` - Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B	N/A
Recruiting	`NCT05894980` - How to Reduce Suicidal Thoughts and Impulsivity in Depression	N/A
Not yet recruiting	`NCT05860257` - Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Digital Dialectical Behavioral Therapy (d-DBT) Skills for Acute Suicidality in Psychiatric Inpatients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms